$12.76
-4.87-27.62%
Last update: Nov 9, 7:57 PM
Janux Therapeutics Inc
JANXNASDAQ
The average analyst price target for Janux Therapeutics is $47.75, 266.5% above the current price. Of 18 analysts, 14 rate it Buy, 3 Hold and 1 Sell. Targets range from $12 to $100. The latest change came on Nov 6, 2026, when Truist Securities raised its price target on Janux Therapeutics from $26 to $27 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 18 Analysts
Rating Trend — Last 9 Months
